National Health (Price and Special Patient Contribution) Amendment Determination 2016 (No. 5) (PB 63 of 2016) (Cth)

Case

PB 63 of 2016

National Health (Price and Special Patient Contribution) Amendment Determination 2016 (No. 5)

National Health Act 1953

I, PENNY SHAKESPEARE, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.

Dated    12 July           2016

PENNY SHAKESPEARE

First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health

1          Name of Instrument

(1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2016 (No. 5).

(2)        This Instrument may also be cited as PB 63 of 2016.

2          Commencement

This Instrument commences on 1 August 2016.

3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).

Schedule 1     Amendments

[1] Schedule 1, entry for Aciclovir

substitute:

Aciclovir Tablet 200 mg Oral Zovirax 200 mg 25 8.30 -
90 - 30.99

[2] Schedule 1, entry for Amlodipine in the form Tablet 5 mg (as besylate)

omit from the column headed “Claimed Price”:          6.85        substitute:             9.10

[3] Schedule 1, entry for Amlodipine in the form Tablet 10 mg (as besylate)

omit from the column headed “Claimed Price”:          9.34        substitute:             9.85

[4] Schedule 1, entry for Clindamycin

omit from the column headed “Claimed Price”:          14.47     substitute:             15.40

[5]Schedule 1, after entry for Diphenoxylate with Atropine

insert:

Donepezil Tablet containing donepezil hydrochloride 5 mg Oral Aricept 28 17.59 23.17
Tablet containing donepezil hydrochloride 10 mg Oral Aricept 28 17.59 23.17

[6] Schedule 1, entry for Doxepin in the form Capsule 10 mg (as hydrochloride)

omit from the column headed “Claimed Price”:          7.87        substitute:             8.27

[7] Schedule 1, entry for Doxepin in the form Capsule 25 mg (as hydrochloride)

omit from the column headed “Claimed Price”:          7.86        substitute:             8.37

[8] Schedule 1, entry for Exemestane

omit from the column headed “Claimed Price”:          73.25     substitute:             75.11

[9] Schedule 1, after entry for Felodipine in the form Tablet 10 mg (extended release)

insert:

Fluconazole Capsule 50 mg Oral Diflucan 28 13.51 17.23

  1. Schedule 1, entry for Glipizide

omit from the column headed “Claimed Price”:          13.33     substitute:             13.78

  1. Schedule 1, entry for Levonorgestrel with Ethinyloestradiol in the form Pack containing 21 tablets 150 micrograms-30 micrograms and 7 inert tablets [Brand: Nordette 28]

omit from the column headed “Claimed Price”:          18.81     substitute:             19.46

  1. Schedule 1, entry for Lisinopril in the form Tablet 10 mg

(a)   omit:

Prinivil 10 30 3.50 5.81

(b)   omit from the column headed “Claimed Price” for the brand “Zestril”:        6.22        substitute:             6.57

  1. Schedule 1, entry for Lisinopril in the form Tablet 20 mg

(a)   omit:

Prinivil 20 30 4.41 6.72

(b)   omit from the column headed “Claimed Price” for the brand “Zestril”:        7.16        substitute:             7.48

  1. Schedule 1, entry for Medroxyprogesterone in the form Injection containing medroxyprogesterone acetate 150 mg in 1 mL

omit from the column headed “Claimed Price”:          18.15     substitute:             18.72

  1. Schedule 1, entry for Medroxyprogesterone in the form Tablet containing medroxyprogesterone acetate 5 mg

omit from the column headed “Claimed Price”:          12.64     substitute:             13.21

  1. Schedule 1, entry for Medroxyprogesterone in the form Tablet containing medroxyprogesterone acetate 10 mg [Pricing Quantity/Pack Quantity: 30]

omit from the column headed “Claimed Price”:          11.59     substitute:             12.16

  1. Schedule 1, entry for Medroxyprogesterone in the form Tablet containing medroxyprogesterone acetate 10 mg [Pricing Quantity/Pack Quantity: 100]

omit from the column headed “Claimed Price”:          26.51     substitute:             27.06

  1. Schedule 1, entry for Methylprednisolone

omit from the column headed “Claimed Price”:          14.48     substitute:             14.94

  1. Schedule 1, entry for Norethisterone with Ethinyloestradiol in each of the forms: Pack containing 21 tablets 500 micrograms-35 micrograms and 7 inert tablets; and Pack containing 21 tablets 1 mg-35 micrograms and 7 inert tablets

omit from the column headed “Claimed Price”:          16.75     substitute:             17.22

  1. Schedule 1, entry for Perindopril with amlodipine in the form Tablet containing 5 mg perindopril arginine with 5 mg amlodipine (as besylate)

omit from the column headed “Claimed Price”:          6.63        substitute:             9.42

  1. Schedule 1, entry for Perindopril with amlodipine in the form Tablet containing 10 mg perindopril arginine with 5 mg amlodipine (as besylate)

omit from the column headed “Claimed Price”:          8.67        substitute:             11.46

  1. Schedule 1, entry for Perindopril with amlodipine in the form Tablet containing 10 mg perindopril arginine with 10 mg amlodipine (as besylate)

omit from the column headed “Claimed Price”:          9.41        substitute:             12.21

  1. Schedule 1, entry for Piroxicam in the form Capsule 10 mg

omit from the column headed “Claimed Price”:          10.33     substitute:             11.19

  1. Schedule 1, entry for Piroxicam in the form Capsule 20 mg

omit from the column headed “Claimed Price”:          9.90        substitute:             10.96

  1. Schedule 1, entry for Piroxicam in the form Dispersible tablet 20 mg

omit from the column headed “Claimed Price”:          10.83     substitute:             10.96

  1. Schedule 1, entry for Quinapril in the form Tablet 5 mg (as hydrochloride)

omit from the column headed “Claimed Price”:          5.79        substitute:             6.35

  1. Schedule 1, entry for Quinapril in the form Tablet 10 mg (as hydrochloride)

omit from the column headed “Claimed Price”:          7.05        substitute:             7.60

  1. Schedule 1, entry for Quinapril in the form Tablet 20 mg (as hydrochloride)

omit from the column headed “Claimed Price”:          8.03        substitute:             8.58

  1. Schedule 1, entry for Spironolactone in the form Tablet 25 mg

omit from the column headed “Claimed Price”:          9.87        substitute:             10.71

  1. Schedule 1, entry for Spironolactone in the form Tablet 100 mg

omit from the column headed “Claimed Price”:          24.10     substitute:             24.40

  1. Schedule 1, entry for Tinidazole

omit from the column headed “Claimed Price”:          7.91        substitute:             9.77

Actions
Download as PDF Download as Word Document
Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0